Agreed. This is a positive development. It looks like Radvac is compiling a best practice open source vaccine development map. They aren't trying to actually produce a vaccine. But they just validated ii key as necessary component of a robust vaccine. Any organization trying to actually produce this map would have to license the ii key rights.
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links